Hong Kong Research

Shrikant Kale joined Jefferies as Senior Microstrategy Research Analyst in May of 2019. Prior to that, he was an Analyst with a highly rated Microstrategy research product at CLSA for more than 12 years. He began his equity research career in 2007 from Mumbai focusing on building bespoke quant products and assisting India strategy research,

Dr. Jing Ma joined Jefferies in June 2025 as a research analyst specializing in China biotech. Jing brings extensive experience in the biotechnology industry as well as venture capitals. Prior to joining Jefferies, Jing worked as Healthcare Investment Director at Vertex Ventures, and Beijing Grains Valley Venture Capital. Before that, Jing also worked for Wuxi

David Shang joined Jefferies in Oct 2024, as a research analyst in China healthcare team. He has rich experience in China healthcare space for 9 years. Previously he worked at Barings Asset Management as healthcare analyst. Prior to that, he was at Citigroup, where he was a member of the II Asia No.1 ranking healthcare

Chu Wang joined Jefferies in Sep 2024, as a research analyst in China Healthcare team. Previously, he worked for Citigroup Research for 3 years, where he was a member of the II Asia No.1 ranking team in healthcare. Prior to that, he was a FICC trader in CDB. He comes with degrees of Bachelor of

Jingjue Pei joined Jefferies HK in 2023 with two years of equity research experience following China consumer and policy research background from her internship with the United Nations and the Economist. Jingjue received a Master of Economics from National University of Singapore and a Bachelor of Finance from Hunan University. She also passed all levels

Jacky He joined Jefferies in August of 2021, following one year as an equity research analyst at China Renaissance covering China technology hardware. Prior to this, he worked as an investment banking analyst at China Securities International. Jacky currently focuses on China technology hardware, and closely follows China semiconductor industry What I am Known For

Cui Cui is Jefferies Head of Asia Healthcare. She ranked No.1 in 2025 Extel(II) Asia Healthcare during her first year at Jefferies, securing first-ever No.1 team ranking for Jefferies Asia. Cui comes with rich experience in healthcare for 12 years in UBS AM and Citigroup as Head of China Healthcare (No.1 in II Asia Healthcare

Zoey Zong joined Jefferies in July 2020 with more than 3 years of equity research experience following China Energy & Petrochemicals at Bank of China International and China Utilities, Industrials and Small & Mid-Caps at Huatai International. What I am Known For How I am Different Upcoming Corporate & Strategic Access

Xiaoyi Lei is a Senior Research Analyst at Jefferies Hong Kong, specializing in China autos and industrial sectors. She leads coverage of 27 stocks across OEMs, Auto Parts, and Heavy-Duty Trucks (HDTs). With the combination of deep dives on emerging technologies, frontline insights from end markets, and a global perspective, Xiaoyi strives to deliver alpha-generating